Empower CBD Clinics Visits Climb By 478% In Q1 As Coronavirus Stress Drives Demand For CBD

With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for. Patient visits increased 800% in February. 590% in March and 480% for Q1. But will Coronavirus social gathering imitations put the clinic network at risk?

No. In fact, it has had the opposite effect, with the clinics being designated an essential service. Moreover, Empower has had to actually increase operating hours due to demand from existing patients who need their CBD medication more than ever, as well as, new patients who are experiencing anxiety and stress through the COVID-19 pandemic.

Moreover, the Company has also entered expanded into telemedicine across multiple states for patients who can't get to a clinic but need a consultation with doctors over the phone to determine the best CBD medications for home delivery.

Watch this interview with the Company's CEO, Steven McAuley, who is Six Sigma certified under the quality initiative of legendary GE chairman Jack Welch. We've never seen a Six Sigma certified CEO in the Canadian small cap markets. Never .... which also explains how McAuley has been able to guide Empower Clinics through the most disruptive retail environment in recent history.

Grab your favourite beverage and settle in to watch what may be your next great small cap investment